Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:32 AM
Study NCT ID:
NCT03401320
Status:
COMPLETED
Last Update Posted:
2024-12-04
First Post:
2018-01-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of IM Letrozole ISM® Pharmacokinetics, Safety, and Tolerability in Healthy Post-menopausal Women (LISA-1)
Sponsor:
Rovi Pharmaceuticals Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-08
First Submit QC Date:
None
Study First Post Date:
2018-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-29
Last Update Post Date:
2024-12-04
Last Update Post Date Type:
ACTUAL